Biomacromolecules · 2005 · 22 citations · 16 references
MedicineBioengineeringPharmacokineticsBiomaterialsBone MetabolismDrug DeliveryBone FormationBone GrowthBone TissueBone Tissue EngineeringExtracellular MatrixOsteogenesisBone Matrix BiochemistryBone Matrix BiologyBone Matrix ProteinsIonic InteractionsIonic StrengthIonic Strength DependenceIonic Strength EffectsSaturation
Recombinant human bone morphogenetic protein-2 (rhBMP-2) promotes bone growth but must be retained at the delivery site for optimal efficacy in vivo. rhBMP-2 release from a collagen-based matrix has shown favorable pharmacokinetics. The present study assessed binding affinity and binding saturation of rhBMP-2 to a collagen matrix as a function of solution and rhBMP-2 isoform variables. Results indicate that rhBMP-2 binds to the collagen matrix with affinities on the order of 10(3) to 10(4) M(-1). Maximum binding, nu, was primarily a function of pH for heterogeneous rhBMP-2 and the extended (T(266)/T(266)) isoform. However, binding saturation of the <Q(283)/<Q(283) isoform was unaffected by pH. Overall, binding saturation was higher than the calculated saturation of a rhBMP-2 monolayer, suggesting both hydrophobic and ionic interactions in a multilayer formation. The contributions of pH and ionic strength to the linkage free energy of interaction was on the order of 1.3 kcal mol(-1) and approximately 0.3 kcal mol(-1), respectively. This thermodynamic approach can serve to optimize interactions between therapeutic proteins and delivery systems.
16
Fernando Lecanda, Louis V. Avioli, Su‐Li Cheng · Journal of Cellular Biochemistry · 1997 · 256 citations
Hasan Uludağ, Darren DʼAugusta, Janet Golden et al. · Journal of Biomedical Materials Research · 2000 · 199 citations
Action Range of BMP Is Defined by Its N-Terminal Basic Amino Acid Core
Bisei Ohkawara, Shun‐ichiro Iemura, Peter ten Dijke et al. · Current Biology · 2002 · 173 citations · Full text